Long-term outcomes of DSNB for cN0 penile cancer

0 Views

07/06/23

Edoardo Pozzi, MD, San Raffaele Scientific Institute, Milan, Italy, talks on the findings of a retrospective analysis investigating the long-term outcomes of dynamic sentinel lymph node biopsy (DSNB) for patients with clinically impalpable (cN0) penile cancer. Data from 509 patients with cN0 penile cancer was analyzed. The study reported that the sensitivity of DSNB was 92.5% and the specificity was 100%. Positive histology following DSNB and subsequent radical lymph node groin dissection was also found to be a strong predictor of reduced cancer specific survival and recurrence-free survival. This interview took place at the virtual European Association of Urology (EAU) Virtual Meeting 2021.